rabbit polyclonal antibody against cd163 Search Results


rabbit polyclonal antibody against cd163  (Biospes Inc)
90
Biospes Inc rabbit polyclonal antibody against cd163
<t>CD163</t> immunostaining showed that ( A ) PDAC Tumor cells were negative (IHCx40) ( B ) High expressions of CD163 in TAM in PDAC (IHCx200) ( C ) High expressions of CD163 in TAM in PDAC (IHCx400) ( D ) Negative expressions in control pancreatic tissue (IHCx200)
Rabbit Polyclonal Antibody Against Cd163, supplied by Biospes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody against cd163/product/Biospes Inc
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibody against cd163 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CD163 immunostaining showed that ( A ) PDAC Tumor cells were negative (IHCx40) ( B ) High expressions of CD163 in TAM in PDAC (IHCx200) ( C ) High expressions of CD163 in TAM in PDAC (IHCx400) ( D ) Negative expressions in control pancreatic tissue (IHCx200)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: CD163 immunostaining showed that ( A ) PDAC Tumor cells were negative (IHCx40) ( B ) High expressions of CD163 in TAM in PDAC (IHCx200) ( C ) High expressions of CD163 in TAM in PDAC (IHCx400) ( D ) Negative expressions in control pancreatic tissue (IHCx200)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Immunostaining, Control

Comparison between PDAC and control groups regarding CD163 staining

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Comparison between PDAC and control groups regarding CD163 staining

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Comparison, Control

High H score values of CD163 staining showed significant associations with ( A ) higher histological grade ( p < 0.026) ( B ) T3 tumor stage ( p < 0.002) ( C ) advanced stage group ( p < 0.001) ( D ) larger tumor size ( p < 0.002) ( E ) Significant direct correlation between high mean H score value of CD163 staining with larger tumor size ( p < 0.031)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: High H score values of CD163 staining showed significant associations with ( A ) higher histological grade ( p < 0.026) ( B ) T3 tumor stage ( p < 0.002) ( C ) advanced stage group ( p < 0.001) ( D ) larger tumor size ( p < 0.002) ( E ) Significant direct correlation between high mean H score value of CD163 staining with larger tumor size ( p < 0.031)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Staining

Relationships between HOXA9 and CD163 in PDAC ( n = 98)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Relationships between HOXA9 and CD163 in PDAC ( n = 98)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques:

Shorter overall survival by univariate survival analysis of PDAC cases showed significant associations with ( A ) Positive virology (HCV infection) ( P < 0.040) ( B ) high direct bilirubin ( P < 0.046) ( C ) larger tumor size ( P < 0.046) ( D ) advanced stage ( P < 0.034) (( E ) high median H score of HOXA9 ( P < 0.015) and CD163 ( P < 0.042)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Shorter overall survival by univariate survival analysis of PDAC cases showed significant associations with ( A ) Positive virology (HCV infection) ( P < 0.040) ( B ) high direct bilirubin ( P < 0.046) ( C ) larger tumor size ( P < 0.046) ( D ) advanced stage ( P < 0.034) (( E ) high median H score of HOXA9 ( P < 0.015) and CD163 ( P < 0.042)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Infection

Multivariate COX regression analysis for the parameters affecting overall survival

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Multivariate COX regression analysis for the parameters affecting overall survival

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Infection

Multivariate COX regression analysis for the parameters affecting overall survival (continuous variables)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Multivariate COX regression analysis for the parameters affecting overall survival (continuous variables)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques:

Univariate and multivariate COX regression analysis for the parameters affecting overall survival in negative Virology (HCV) cases

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Univariate and multivariate COX regression analysis for the parameters affecting overall survival in negative Virology (HCV) cases

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques:

Univariate overall survival of PDAC cases (53 cases)

Journal: Diagnostic Pathology

Article Title: HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

doi: 10.1186/s13000-024-01563-5

Figure Lengend Snippet: Univariate overall survival of PDAC cases (53 cases)

Article Snippet: Immunostaining was done using an IgG anti- HOXA9 rabbit’s polyclonal antibody (0.1 mL concentrated and diluted 1:150) (Chongqing Biospes Co., Ltd, China. catalog# YPA2228) and Rabbit polyclonal antibody against CD163 (Chongqing Biospes Co., Ltd, China. cat. # YPA1450), 100 ul concentrated with dilution of 1:100 as primary antibodies.

Techniques: Infection